12:00 AM
 | 
Aug 29, 2011
 |  BC Week In Review  |  Clinical News  |  Clinical Results

Digital ELISA: Pilot trial data

Researchers at Quanterix and the Mayo Clinic reported data from a pilot trial in plasma samples from 17 patients with CD who received anti-TNF alpha therapy showing that Quanterix's Digital ELISA using SiMoA technology was able to quantify measurements of the inflammatory biomarkers TNF...

Read the full 199 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$35 USD
More Info >